Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

scPharmaceuticals Q4 2023 GAAP EPS $(0.35) Beats $(0.42) Estimate, Sales $6.096M Beat $5.525M Estimate

Author: Benzinga Newsdesk | March 13, 2024 04:07pm
scPharmaceuticals (NASDAQ:SCPH) reported quarterly losses of $(0.35) per share which beat the analyst consensus estimate of $(0.42) by 16.67 percent. This is a 16.67 percent decrease over losses of $(0.30) per share from the same period last year. The company reported quarterly sales of $6.096 million which beat the analyst consensus estimate of $5.525 million by 10.33 percent.

Posted In: SCPH


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist